Newswise — The ARVO Foundation for Eye Research, a supporting non-profit of the Association for Research in Vision and Ophthalmology (ARVO), today announced the recipients of the 2007 ARVO/Alcon Early Career Clinician-Scientist Research Awards. The awards will be presented on Sunday, May 6, during the ARVO/Alcon Keynote Session at the 2007 ARVO Annual Meeting in Fort Lauderdale, Fla. The awards are funded by a donation to the Foundation from Alcon Laboratories.
Designed to recognize the importance of clinician-scientists in the ophthalmic research community, the awards are given based on the quality of each recipient's research presented at the ARVO Annual Meeting. The awardees, who will receive grants of $3,000 each, are clinicians with an academic faculty or comparable appointment committed to a career with protected research time. They also work or have previously worked under the guidance of a mentor.
This year's recipients are: Nitza Goldenberg-Cohen, MD, Schneider Children's Medical Center, Shoham, Israel; Andras M. Komaromy, DVM, PhD, University of Pennsylvania School of Veterinary Medicine, Philadelphia; Rainer A. Leitgeb, PhD, Ecole Polytechnique Federale, Lausanne, Switzerland; Malin Malmsjo, MD, PhD, Lund University, Sweden; Takahiro Suzuki, MD, PhD, Tokai University School of Medicine, Ishehara, Japan.
The abstracts on which the awards were based are: Goldenberg-Cohen, "Enhanced Neuronal Differentiation of Bone Marrow Derived Stem Cells in Ischemic Retina," Komaromy, "Cone-Directed Gene Therapy with rAAV Leads to Restoration of Cone Function in a Canine Model of Achromatopsia;" Leitgeb, "Macular Pigment Optical Density (MPOD), Serum C-Reactive Protein (CRP), and Serum Lutein and Zeaxanthin (L&Z) in Age-Related Maculopathy (ARM);" Malmsjo, "Retinal Ischemia Reperfusion: A New Animal Model Suitable for Experimental Analysis of the Retinal Arteries;" and Suzuki, "Improvement of Pathological Neovascularization and Astrocyte Abnormalities in a Mouse Model of Oxygen-Induced Retinopathy by Augmenting Bone Marrow-Derived Endothelial Progenitor Cell Recruitment via Lnk Deletion."
Founded in 2002, the ARVO Foundation for Eye Research is a supporting organization of the Association for Research in Vision and Ophthalmology (ARVO). The Foundation provides continuing education and stable support for original and innovative vision research, particularly with translational impact fostering collaboration between clinicians and basic scientists. The Foundation also supports training for new vision research scientists, including those in developing countries. For more information about the ARVO Foundation for Eye Research, logon to http://www.arvofoundation.org.
ARVO is a membership organization of more than 11,700 eye and vision researchers from over 70 countries. Established in 1928, the Association encourages and assists its members and others in research, training, publication, and dissemination of knowledge in vision and ophthalmology. ARVO's headquarters are located in Rockville, Md. For more information about ARVO, logon to http://www.arvo.org.
Alcon, Inc. is the world's leading eye care company with sales exceeding $4.89 billion in 2006. Alcon, which has been dedicated to the ophthalmic industry for over 50 years, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens solutions and other vision care products that treat diseases, disorders and other conditions of the eye. For more information on Alcon, Inc., visit the company's Web site at http://www.alconinc.com.
RSS